America February 24, 2026
Slate Medicines Raises $130 Million Series A to Advance Anti-PACAP Monoclonal Antibody for Migraine Prevention
Slate Medicines Inc., a Raleigh, North Carolina-based biotechnology company focused on next-generation treatments for headache disorders, announced Tuesday it has…